Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6143292

Title:Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
Inventors:Slavin, Shimon; Jerusalem, Israel
Summary:Described herein are allogeneic lymphocytes and methods of their use. The invention relates to a process of administering allogeneic lymphocytes in the treatment of a human cancer patient having a solid malignant tumor. Specific therapeutic applications are provided, such as for inducing a graft-versus-tumor response in the treatment of solid tumors and leukemia with allogeneic lymphocytes after allogeneic stem cell transplantation.
Abstract:A method of treating a human cancer patient having a solid tumor comprising malignant cells is disclosed, wherein the patient having undergone a cancer therapy regimen comprising allogeneic stem cell transplantation. The method comprises administering allogeneic lymphocytes to the patient and monitoring the patient for levels of malignant cells.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6143292
Application Number:US1997000930071
Date Filed:21/11/1997
Date Published:07/11/2000
Assignee:Baxter International Inc., Deerfield, IL, USA


 
Copyright © 2007 The Institute for Cellular Medicine  8/10/2020